acquisition

[ad_1] Kotak Special Situations Fund, managed by Kotak Investment Advisors, on Wednesday announced an investment of Rs 1,070 crore in Biocon. The proceeds will be used to finance Biocon Biologics’ acquisition of the biosimilars business of its partner Viatris to create a global vertically integrated biosimilars player. With the current Read more…